168 related articles for article (PubMed ID: 18004283)
1. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine.
Brown ES; Wolfshohl J; Shad MU; Vazquez M; Osuji IJ
Neuropsychopharmacology; 2008 Sep; 33(10):2376-83. PubMed ID: 18004283
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.
Brown ES; Sayed N; Choi C; Tustison N; Roberts J; Yassa MA; Van Enkevort E; Nakamura A; Ivleva EI; Sunderajan P; Khan DA; Vazquez M; McEwen B; Kulikova A; Frol AB; Holmes T
Eur Neuropsychopharmacol; 2019 Mar; 29(3):376-383. PubMed ID: 30612854
[TBL] [Abstract][Full Text] [Related]
3. Effects of lamotrigine on hippocampal activation in corticosteroid-treated patients.
Brown ES; Zaidel L; Allen G; McColl R; Vazquez M; Ringe WK
J Affect Disord; 2010 Nov; 126(3):415-9. PubMed ID: 20580827
[TBL] [Abstract][Full Text] [Related]
4. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy.
Brown ES; Stuard G; Liggin JD; Hukovic N; Frol A; Dhanani N; Khan DA; Jeffress J; Larkin GL; McEwen BS; Rosenblatt R; Mageto Y; Hanczyc M; Cullum CM
Biol Psychiatry; 2005 Mar; 57(5):543-8. PubMed ID: 15737670
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy.
Desai S; Khanani S; Shad MU; Brown ES
J Clin Psychopharmacol; 2009 Jun; 29(3):284-7. PubMed ID: 19440084
[TBL] [Abstract][Full Text] [Related]
6. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy.
Brown ES; Vazquez M; Nakamura A
Biol Psychiatry; 2008 Oct; 64(8):727-729. PubMed ID: 18582848
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes.
Brown ES; Lu H; Denniston D; Uh J; Thomas BP; Carmody TJ; Auchus RJ; Diaz-Arrastia R; Tamminga C
J Affect Disord; 2013 Sep; 150(2):551-8. PubMed ID: 23453674
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy.
Brown ES; J Woolston D; Frol A; Bobadilla L; Khan DA; Hanczyc M; Rush AJ; Fleckenstein J; Babcock E; Cullum CM
Biol Psychiatry; 2004 Mar; 55(5):538-45. PubMed ID: 15023583
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of an NMDA receptor antagonist for reversing corticosteroid effects on the human hippocampus.
Brown ES; Kulikova A; Van Enkevort E; Nakamura A; Ivleva EI; Tustison NJ; Roberts J; Yassa MA; Choi C; Frol A; Khan DA; Vazquez M; Holmes T; Malone K
Neuropsychopharmacology; 2019 Dec; 44(13):2263-2267. PubMed ID: 31181564
[TBL] [Abstract][Full Text] [Related]
10. Effect of two prednisone exposures on mood and declarative memory.
Brown ES; Beard L; Frol AB; Rush AJ
Neurobiol Learn Mem; 2006 Jul; 86(1):28-34. PubMed ID: 16458545
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.
Belsito KM; Law PA; Kirk KS; Landa RJ; Zimmerman AW
J Autism Dev Disord; 2001 Apr; 31(2):175-81. PubMed ID: 11450816
[TBL] [Abstract][Full Text] [Related]
12. Mesial temporal lobe epilepsy: Revisiting the relation of hippocampal volumetry with memory deficits.
Ono SE; de Carvalho Neto A; Joaquim MJM; Dos Santos GR; de Paola L; Silvado CES
Epilepsy Behav; 2019 Nov; 100(Pt A):106516. PubMed ID: 31574430
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexamethasone on declarative memory function in posttraumatic stress disorder.
Bremner JD; Vythilingam M; Vermetten E; Afzal N; Nazeer A; Newcomer JW; Charney DS
Psychiatry Res; 2004 Nov; 129(1):1-10. PubMed ID: 15572179
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts.
Brown ES; Denniston D; Gabrielson B; Khan DA; Khanani S; Desai S
Allergy Asthma Proc; 2010; 31(4):331-6. PubMed ID: 20819324
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.
Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH
Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913
[TBL] [Abstract][Full Text] [Related]
16. Long-term declarative memory deficits in diffuse TBI: correlations with cortical thickness, white matter integrity and hippocampal volume.
Palacios EM; Sala-Llonch R; Junque C; Fernandez-Espejo D; Roig T; Tormos JM; Bargallo N; Vendrell P
Cortex; 2013 Mar; 49(3):646-57. PubMed ID: 22482692
[TBL] [Abstract][Full Text] [Related]
17. Impact of levetiracetam on mood and cognition during prednisone therapy.
Brown ES; Frol AB; Khan DA; Larkin GL; Bret ME
Eur Psychiatry; 2007 Oct; 22(7):448-52. PubMed ID: 17766093
[TBL] [Abstract][Full Text] [Related]
18. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
[TBL] [Abstract][Full Text] [Related]
19. A double-blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine: effects on CSF glutamate, aspartate, branched-chain amino acid levels and clinical parameters.
Ryberg H; Askmark H; Persson LI
Acta Neurol Scand; 2003 Jul; 108(1):1-8. PubMed ID: 12807386
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder.
Vermetten E; Vythilingam M; Southwick SM; Charney DS; Bremner JD
Biol Psychiatry; 2003 Oct; 54(7):693-702. PubMed ID: 14512209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
